Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05611931 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 220 participants |
| Active Locations | 80 sites in the US |
| Sponsor | Karyopharm Therapeutics Inc |
| Last Updated on CT.gov | February 2, 2026 (4 weeks ago) |
As of March 2, 2026: Clinical trial NCT05611931 is currently recruiting participants. This clinical trial study for endometrial cancer is actively seeking new participants at 80 locations across the United States. The study is sponsored by Karyopharm Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05611931 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 80 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05611931 was last updated 4 weeks ago (February 2, 2026). HelloStudys verifies this status automatically.